Tag: Ga-68 DOTANOC
-
Ga-68 DOTANOC PET/CT in Cardiac Sarcoidosis: A New Tool for Assessing Therapy Response
Overview: Ga-68 DOTANOC as an inflammation tracer in cardiac sarcoidosis Cardiac sarcoidosis (CS) is a granulomatous inflammatory disease affecting the heart, often with serious outcomes if not treated appropriately. Immunosuppressive therapy, typically steroids with possible addition of other agents, remains the mainstay of management. Traditional imaging has focused on identifying disease activity and guiding therapy.…
-
Ga-68 DOTANOC PET/CT: A New Lens for Assessing Therapy Response in Cardiac Sarcoidosis
Introduction Cardiac sarcoidosis is an inflammatory granulomatous disease of the heart that carries substantial morbidity and mortality if not properly managed. Immunosuppressive therapy, often steroids, remains the cornerstone of treatment. While traditional imaging modalities help diagnose cardiac involvement, tracking the response to therapy requires reliable, repeatable biomarkers of inflammation. Recent prospective data from a study…
-
Ga-68 DOTANOC PET/CT for Response Assessment in Cardiac Sarcoidosis: A Prospective Study
Introduction Cardiac sarcoidosis is an inflammatory granulomatous disease of the heart that carries significant morbidity and mortality. Immunosuppressive therapy is the cornerstone of treatment, aiming to reduce myocardial inflammation and preserve cardiac function. This prospective observational study evaluates the usefulness of Ga-68 DOTANOC PET/CT, a somatostatin receptor imaging modality, for assessing treatment response in cardiac…